Infusion Lounges vs Traditional IV Therapy: Why Healthcare Leaders Are Making the Shift

Demand for infusion services in the United States continues to grow, driven largely by increased use of biologics and by chronic disease management moving into outpatient settings. That growth is not flowing equally to all settings. Hospital-based infusion programs carry high overhead, complex workflows, and patient experiences that often feel clinical rather than comfortable. Outpatient infusion lounges - agile, patient-centered, and built for ongoing treatment relationships - are capturing a growing share of that demand.

Healthcare leaders making this shift are not doing it because infusion lounges are a trend. They are doing it because the operational and financial case is strong, patient preference is clear, and the model fits how chronic disease management actually works.

Defining the terms clearly

Infusion therapy is the method - intravenous medication delivery, applicable across hospital, outpatient, and home settings.

Infusion lounge or infusion suite is a specific outpatient model that prioritizes patient comfort - recliners, natural lighting, entertainment, privacy - while maintaining clinical standards. The care does not change. The environment does.

The distinction matters because many administrators conflate the two. The clinical protocols in an infusion lounge are equivalent to those in a hospital outpatient department. What changes is the setting, the cost structure, and the patient experience - all in favor of the lounge model.

One scoping note. This article addresses medical infusion - biologics, IV antibiotics, IV iron, and similar physician-ordered therapies. It does not address elective IV wellness services such as vitamin drips or hydration bars. Those are regulated differently under state scope-of-practice and med-spa rules, are generally self-pay rather than payer-reimbursed, and are not 340B-eligible.

What the evidence says about patient preference and safety

The National Infusion Center Association found that 78% of patients receiving chronic infusions prefer standalone infusion centers over hospitals. Two things to keep in mind about that figure: NICA is a trade association representing non-hospital infusion providers, so the finding aligns with its members' interests, and the year the survey was conducted is not stated in the way the number is usually cited. It is a directionally useful data point rather than an independent one. For patients managing ongoing biologics for autoimmune conditions, multiple sclerosis, or Crohn's disease, the underlying preference is not trivial - it affects whether they complete their treatment courses.

On safety, a 2021 review in the Journal of Infusion Nursing found no significant difference in adverse event rates between hospital outpatient departments and standalone infusion centers. That is a meaningful finding, but it does not settle site of care on its own. Whether a given therapy and a given patient are suited to a lounge setting depends on the protocols in place, the training of the staff delivering care, the site's emergency preparedness for reactions and anaphylaxis, and the patient's acuity and comorbidities. The setting is not the variable that determines safety; the program built inside it is.

The economics: why the lounge model often wins

Hospital billing for infusion typically runs under Medicare Part B and includes facility fees that significantly increase total cost. Payers pay more, patients pay more, and the hospital's cost structure is built into every encounter.

Outpatient infusion lounges are commonly billed as physician-administered services without a separate facility fee, which reduces payer cost and can improve the lounge's position in payer negotiations. But site-of-service billing is not uniform. It varies by payer, by state, and by entity type, and it depends on how the location is enrolled and whether it is provider-based. FQHCs in particular behave differently: encounters generally fall under PPS with wrap-around payment rather than fee-for-service physician billing, which changes the arithmetic entirely. Before modeling revenue on any of this, have your billing compliance team or outside counsel confirm how your specific sites and contracts will actually pay.

The math can improve further for FQHCs and other 340B covered entities, where 340B acquisition cost combines with administration reimbursement. That combination is real, but it is available only after several prerequisites are satisfied. Before purchasing 340B drugs for a new infusion location, the entity needs to confirm:

• The location is registered as a child site on the entity's record in HRSA's Office of Pharmacy Affairs database, and is listed on the entity's most recent reimbursable cost report or otherwise meets the criteria for registration.
• The site operates within the entity's scope of project, and every recipient of a 340B-purchased drug meets the 340B patient definition.
• The entity's Medicaid carve-in or carve-out status is correctly reflected on the Medicaid Exclusion File, so that 340B purchases do not generate duplicate discounts alongside Medicaid rebates.
• Whether the GPO prohibition applies to its entity type - it binds DSH hospitals, children's hospitals, and freestanding cancer hospitals, and getting this wrong on the outpatient drug side is a common audit finding.

Skipping these steps does not make the economics work faster. It makes the purchases diversion.

How care delivery differs

Hospital infusion centers run complex workflows, manage multiple service lines simultaneously, and carry overhead that reflects the broader institution. Scheduling flexibility is limited. Wait times can be long. The experience is clinical and often impersonal.

Infusion lounges operate with nurse-led care, physician oversight via EHR or telehealth, and workflows designed around infusion specifically. Scheduling is flexible. Turnover is faster. The experience is designed to be one patients do not dread.

For patients receiving six to eight hour infusions every few weeks, that distinction drives whether they show up consistently or start finding reasons to reschedule.

What to assess before making the shift

Before moving toward an infusion lounge model, administrators should work through three practical questions:

Space. Do you have approximately 250 square feet available? Unused exam rooms are a common and effective starting point. The room needs a sink and enough space for a recliner, IV stand, and monitoring equipment. Treat that as a planning heuristic rather than a specification - actual requirements depend on your state's facility licensure rules, applicable life-safety code, ADA and accessibility requirements, and, wherever drug preparation or compounding occurs on site, USP General Chapter <797> standards for sterile compounding.

Staffing. Can you hire and train IV therapy nurses, or partner with a staffing agency that specializes in infusion? The clinical competency requirement is real - infusion nursing is a specialty, and the program's safety depends on having staff who are trained for it.

Payer mix. Is your current payer mix favorable for outpatient infusion billing? The economics differ by payer and by the specific therapies you plan to offer. A realistic financial model, built on your actual patient population, is the right starting point - not a generic projection.

The shift is a complement, not a replacement

Infusion lounges are not a replacement for hospital-based infusion in cases where acute complexity, monitoring requirements, or risk profile call for that setting. They are a complement - one that can handle many chronic outpatient infusions more efficiently, more comfortably, and often more profitably. Which therapies belong in which setting, and which individual patients are suited to each, is a per-therapy and per-patient determination made by the treating provider against the site's protocols and capabilities, not something a site-of-care strategy decides in advance.

The organizations making this shift are not abandoning clinical rigor. They are building a model that delivers that rigor in a setting that works better for the patients they are trying to retain.

If you are evaluating an infusion lounge model and want to understand what the build-out, staffing, and financial structure looks like in practice, contact Remy to talk through the specifics for your organization.